Concepedia

Christopher W. Allard

CW

3

Publications

96

Citations

3

H-Index

2019

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Christopher W. Allard is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, natural sciences, and drug discovery.

Top concepts

Publications per year

2019–2021

3

Publications

3

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan, Godwin Kumi, Christopher W. Allard et al. · ACS Medicinal Chemistry Letters · 2021 · 51 citations · Full text

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Kevin M. Peese, Christopher W. Allard, Timothy P. Connolly et al. · Journal of Medicinal Chemistry · 2019 · 35 citations

, , +15

Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors

Manoj Patel, Christopher Cianci, Christopher W. Allard et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 10 citations

Rows per page

1–3 of 3